Paper7409232
A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
Fotherby K and 6 others. Fertil Steril, 1980. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate. Papers, record 7409232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7409232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Medroxyprogesterone | Major topic |
| Norethindrone | Major topic |
| Adult | |
| Blood Chemical Analysis | |
| Body Weight | |
| Delayed-Action Preparations | |
| Female | |
| Hematologic Tests | |
| Humans | |
| Kinetics | |
| Menstruation | |
| Ovarian Function Tests |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41489365 | Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†. | Biol Reprod | 2026 | https://conductscience.org/library/papers/41489365 | PubMed |
| 39106301 | U.S. Selected Practice Recommendations for Contraceptive Use, 2024. | MMWR Recomm Rep | 2024 | https://conductscience.org/library/papers/39106301 | PubMed |
| 38530848 | Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. | PLoS One | 2024 | https://conductscience.org/library/papers/38530848 | PubMed |
| 38134043 | Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. | PLoS One | 2023 | https://conductscience.org/library/papers/38134043 | PubMed |
| 35964796 | Variability and quantification of serum medroxyprogesterone acetate levels. | Steroids | 2022 | https://conductscience.org/library/papers/35964796 | PubMed |
| 35941737 | Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/35941737 | PubMed |
| 33316287 | Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33316287 | PubMed |
| 30867477 | The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations. | Sci Rep | 2019 | https://conductscience.org/library/papers/30867477 | PubMed |
| 30585845 | HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa. | AIDS | 2019 | https://conductscience.org/library/papers/30585845 | PubMed |
| 29698514 | Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels. | PLoS One | 2018 | https://conductscience.org/library/papers/29698514 | PubMed |
| 29309550 | Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms. | Endocr Rev | 2018 | https://conductscience.org/library/papers/29309550 | PubMed |
| 29242082 | Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV? | Contraception | 2018 | https://conductscience.org/library/papers/29242082 | PubMed |
| 24174884 | Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. | Int J Womens Health | 2013 | https://conductscience.org/library/papers/24174884 | PubMed |
| 16856087 | Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/16856087 | PubMed |
| 6223801 | Long acting contraceptives. Present status. | Drugs | 1983 | https://conductscience.org/library/papers/6223801 | PubMed |
| 6213318 | Facts about injectable contraceptives: memorandum from a WHO meeting. | Bull World Health Organ | 1982 | https://conductscience.org/library/papers/6213318 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7409232
GET https://conductscience.org/api/papers/v1/7409232/authors